Kemper
KMPR
#4862
Rank
$1.79 B
Marketcap
$30.56
Share price
1.36%
Change (1 day)
-53.78%
Change (1 year)

Kemper - 10-Q quarterly report FY


Text size:
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

[X] Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

For Quarterly Period Ended September 30, 2001
----------------------------------------------------
OR

[_] Transition Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

For the Transition Period from _____________________ to _______________________

Commission file 0-18298
number
---------------------------------------------------------

Unitrin, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)

Delaware 95-4255452
--------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employeer
incorporation or organization) Identification No.)

One East Wacker Drive, Chicago, Illinois 60601
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)


(312)661-4600
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)

Not Applicable
--------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since last
report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

Yes X No______
---

67,301,351 shares of common stock, $0.10 par value, were outstanding as of
September 30, 2001.
UNITRIN, INC.


INDEX

<TABLE>
<CAPTION>
Page
------
<S> <C>
PART I. Financial Information.

Item 1. Financial Statements

Condensed Consolidated Statements of Income for the Three and Nine
Months Ended September 30, 2001 and 2000 (Unaudited). 1

Condensed Consolidated Balance Sheets as of September 30, 2001
(Unaudited) and December 31, 2000. 2

Condensed Consolidated Statements of Cash Flows for the Nine Months
Ended September 30, 2001 and 2000 (Unaudited). 3

Notes to the Condensed Consolidated Financial Statements (Unaudited). 4-10

Item 2. Management's Discussion and Analysis of Results of Operations and
Financial Condition. 11-18

Item 3. Quantitative and Qualitative Disclosures About Market Risk. 19-21

PART II. Other Information.

Item 1. Legal Proceedings. 22

Item 6. Exhibits and Reports on Form 8-K. 22-23

Signatures 24
</TABLE>
UNITRIN, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in millions, except per share amounts)
(Unaudited)


<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
----------------------------- ------------------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
2001 2000 2001 2000
----------- ------------ -------------- -------------
<S> <C> <C> <C> <C>
Revenues:
Premiums $ 1,160.6 $ 1,083.8 $ 405.4 $ 363.9
Consumer Finance Revenues 119.0 103.9 40.7 36.3
Net Investment Income 177.0 167.5 61.3 58.1
Net Gains on Sales of Investments 563.8 133.2 1.2 37.8
----------- ------------ -------------- -------------
Total Revenues 2,020.4 1,488.4 508.6 496.1
----------- ------------ -------------- -------------

Expenses:
Insurance Claims and Policyholders' Benefits 865.9 785.5 298.8 245.1
Insurance Expenses 461.3 463.4 156.2 145.6
Consumer Finance Expenses 96.4 85.0 31.4 29.8
Interest and Other Expenses 15.4 29.8 7.1 18.8
----------- ------------ -------------- -------------
Total Expenses 1,439.0 1,363.7 493.5 439.3
----------- ------------ -------------- -------------

Income before Income Taxes and Equity
in Net Income (Loss) of Investees 581.4 124.7 15.1 56.8
Income Tax Expense 204.6 43.8 4.1 18.6
----------- ------------ -------------- -------------
Income before Equity in Net Income (Loss) of Investees 376.8 80.9 11.0 38.2
Equity in Net Income (Loss) of Investees 16.2 (17.8) 9.1 (42.5)
----------- ------------ -------------- -------------
Net Income (Loss) $ 393.0 $ 63.1 $ 20.1 $ (4.3)
=========== ============ ============== =============
Net Income (Loss) Per Share $ 5.82 $ 0.91 $ 0.30 $ (0.06)
=========== ============ ============== =============
Net Income (Loss) Per Share Assuming Dilution $ 5.78 $ 0.91 $ 0.30 $ (0.07)
=========== ============ ============== =============
</TABLE>


The Notes to the Condensed Consolidated Financial Statements are an integral
part of these financial statements.


1
UNITRIN, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in millions, except per share amounts)

<TABLE>
<CAPTION>
September 30, December 31,
2001 2000
-------------- --------------
(Unaudited)

<S> <C> <C>
Assets:
Investments:
Fixed Maturities at Fair Value (Amortized
Cost: 2001 - $2,579.1; 2000 - $2,729.9) $ 2,654.1 $ 2,733.2
Equity Securities at Fair Value
(Cost: 2001 - $1,128.7; 2000 - $205.7) 1,361.1 367.8
Investees at Cost Plus Cumulative Undistributed Earnings
(Fair Value: 2001 - $260.5; 2000 - $1,245.7) 194.5 620.0
Short-term Investments at Cost which Approximates Fair Value 818.6 271.2
Other 241.6 241.3
-------------- --------------
Total Investments 5,269.9 4,233.5
-------------- --------------

Cash 27.5 23.3
Consumer Finance Receivables at Cost (Fair
Value: 2001 - $726.1; 2000 - $677.8) 729.7 681.1
Other Receivables 455.2 420.5
Deferred Policy Acquisition Costs 332.0 322.2
Goodwill 346.8 353.2
Other Assets 114.7 131.0
-------------- --------------
Total Assets $ 7,275.8 $ 6,164.8
============== ==============

Liabilities and Shareholders' Equity:
Insurance Reserves:
Life and Health $ 2,139.9 $ 2,101.4
Property and Casualty 596.5 541.4
-------------- --------------
Total Insurance Reserves 2,736.4 2,642.8
-------------- --------------

Investment Certificates and Savings Accounts at Cost
(Fair Value: 2001 - $752.2 ; 2000 - $698.6) 749.4 703.4
Unearned Premiums 437.9 385.3
Accrued and Deferred Income Taxes 470.9 248.1
Notes Payable 207.8 180.0
Accrued Expenses and Other Liabilities 583.3 304.0
-------------- --------------
Total Liabilities 5,185.7 4,463.6
-------------- --------------

Shareholders' Equity:
Common Stock, $0.10 par value, 100 million Shares Authorized; 67,301,351 and
67,648,447 Shares Issued and Outstanding at
September 30, 2001 and December 31, 2000 6.7 6.8
Paid-in Capital 463.4 442.6
Retained Earnings 1,426.3 1,150.2
Accumulated Other Comprehensive Income 193.7 101.6
-------------- --------------
Total Shareholders' Equity 2,090.1 1,701.2
-------------- --------------
Total Liabilities and Shareholders' Equity $ 7,275.8 $ 6,164.8
============== ==============
</TABLE>


The Notes to the Condensed Consolidated Financial Statements are an integral
part of these financial statements.

2
UNITRIN, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in millions)
(Unaudited)

<TABLE>
<CAPTION>
Nine Months Ended
-----------------------------
September 30, September 30,
2001 2000
------------- -------------
<S> <C> <C>
Operating Activities:
Net Income $ 393.0 $ 63.1
Adjustment to Reconcile Net Income to Net Cash
Provided (Used) by Operations:
Change in Deferred Policy Acquisition Costs (6.6) (6.3)
Equity in Net (Income)Loss of Investees before Taxes (24.6) 28.2
Cash Dividends from Investee 1.1 1.1
Amortization of Investments 0.3 10.6
Increase in Receivables (34.8) (49.4)
Increase in Insurance Reserves and Unearned Premiums 141.0 127.6
Increase (Decrease) in Accrued and Deferred Income Taxes 174.5 (51.4)
Increase in Accrued Expenses and Other Liabilities 40.9 41.7
Net Gains on Sale of Investments (563.8) (133.2)
Provision for Loan Losses 22.2 20.3
Other, Net 21.1 24.8
------------ -------------
Net Cash Provided by Operating Activities 164.3 77.1
------------ -------------

Investing Activities:
Sales and Maturities of Fixed Maturities 837.3 766.7
Purchases of Fixed Maturities (688.3) (922.2)
Sales and Redemptions of Equity Securities 8.8 357.8
Purchases of Equity Securities (91.0) --
Sale of Litton Common Stock, Net 171.8 --
Disposition of Businesses, Net of Cash Disposed -- 33.1
Change in Consumer Finance Receivables (70.6) (86.9)
Change in Short-term Investments (543.3) (210.9)
Other, Net (1.1) (9.2)
------------ -------------
Net Cash Used by Investing Activities (376.4) (71.6)
------------ -------------

Financing Activities:
Change in Investment Certificates and Savings Accounts 46.0 72.3
Change in Universal Life and Annuity Contracts 5.1 6.9
Change in Liability for Funds Held for Securities on Loan 234.2 --
Notes Payable Proceeds 499.0 490.7
Notes Payable Payments (471.0) (395.7)
Cash Dividends Paid (81.1) (77.7)
Common Stock Repurchases (26.0) (107.9)
Other, Net 10.1 2.2
------------ -------------
Net Cash Provided (Used) by Financing Activities 216.3 (9.2)
------------ -------------
Increase (Decrease) in Cash 4.2 (3.7)
Cash, Beginning of Year 23.3 24.1
------------ -------------
Cash, End of Period $ 27.5 $ 20.4
============ =============
</TABLE>

The Notes to the Condensed Consolidated Financial Statements are an integral
part of these financial statements.

3
UNITRIN, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note 1 - Basis of Presentation

The unaudited Condensed Consolidated Financial Statements included herein have
been prepared by Unitrin, Inc. ("Unitrin" or the "Company") pursuant to the
rules and regulations of the Securities and Exchange Commission but do not
include all information and footnotes required by accounting principles
generally accepted in the United States of America ("GAAP"). In the opinion of
the Company's management, the unaudited Condensed Consolidated Financial
Statements reflect all adjustments necessary for a fair presentation. Certain
prior year amounts have been reclassified to conform to the current year's
presentation. The preparation of interim financial statements relies heavily on
estimates. This factor and certain other factors, such as the seasonal nature of
some portions of the insurance business, as well as market conditions, call for
caution in drawing specific conclusions from interim results. The accompanying
unaudited Condensed Consolidated Financial Statements should be read in
conjunction with the Consolidated Financial Statements and related notes
included in the Company's Annual Report on Form 10-K, filed with the Commission
for the year ended December 31, 2000.

In the second quarter of 2001, the Company revised the management reporting of
its segment results. The businesses that constituted the Property & Casualty
Insurance segment will now be reported as two distinct segments: Multi Lines
Insurance segment and Specialty Lines Insurance segment. Prior period amounts
have been reclassified to conform to the revised reporting. This change had no
effect on net income.


Note 2 - Net Income Per Share

Net Income (Loss) Per Share and Net Income (Loss) Per Share Assuming Dilution
determined in accordance with Statement of Financial Accounting Standards
("SFAS") No. 128, "Earnings Per Share" for the nine and three months ended
September 30, 2001 and 2000 were as follows:


<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
--------------------- ---------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars and Shares in Millions, Except Per Share Amounts) 2001 2000 2001 2000
------------------------------------------------------------ --------- --------- --------- ---------
<S> <C> <C> <C> <C>
Net Income (Loss) $ 393.0 $ 63.1 $ 20.1 $ (4.3)
Dilutive Effect on Net Income from
Investees' Equivalent Shares (0.4) (0.3) (0.1) (0.2)
-------- -------- -------- -------
Net Income (Loss) Assuming Dilution $ 392.6 $ 62.8 $ 20.0 $ (4.5)
======== ======== ======== =======

Weighted Average Common Shares Outstanding 67.5 69.0 67.4 68.2
Dilutive Effect of Unitrin Stock Option Plans 0.4 0.1 0.3 0.1
-------- -------- -------- -------
Weighted Average Common Shares and
Equivalent Shares Outstanding Assuming Dilution 67.9 69.1 67.7 68.3
======== ======== ======== =======

Net Income (Loss) Per Share $ 5.82 $ 0.91 $ 0.30 $ (0.06)
======== ======== ======== =======

Net Income (Loss) Per Share Assuming Dilution $ 5.78 $ 0.91 $ 0.30 $ (0.07)
======== ======== ======== =======
</TABLE>

4
Note 3 - Investment in Investees

Unitrin accounts for its Investments in Investees (Curtiss-Wright Corporation
("Curtiss-Wright") and UNOVA, Inc. ("UNOVA")) and, formerly, Litton Industries,
Inc. ("Litton") under the equity method of accounting using the most recent and
sufficiently timely publicly-available financial reports and other
publicly-available information which generally results in a two or
three-month-delay basis depending on the investee being reported.

Equity in Net Income (Loss) of Investees was income of $16.2 million and $9.1
million for the nine and three months ended September 30, 2001, respectively,
compared to a loss of $17.8 million and $42.5 million for the nine and three
months ended September 30, 2000, respectively. Equity in Net Income (Loss) of
Investees for each of the Company's investee companies for the nine and three
months ended September 30, 2001 and 2000 was:


<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
--------------------- ---------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
----------------------------------- -------- -------- -------- --------
<S> <C> <C> <C> <C>
Curtiss-Wright Corporation $ 8.7 $ 8.4 $ 3.1 $ 3.2
Litton Industries, Inc. 8.8 30.2 - 12.6
UNOVA, Inc. (1.3) (56.4) 6.0 (58.3)
-------- -------- -------- --------
Equity In Net Income (Loss) of
Investees $ 16.2 $ (17.8) $ 9.1 $ (42.5)
======== ======== ======== ========
</TABLE>


Unitrin's proportionate share of UNOVA's results for both the nine and three
months ended September 30, 2001 includes an after tax gain of $5.3 million as a
result of UNOVA's completion of a partial settlement of its defined benefit
pension obligations through the purchase of annuity contracts. Unitrin's
proportionate share of UNOVA's results for the nine and three months ended
September 30, 2001, also includes an after-tax loss of $3.2 million and $0.4
million, respectively, related to UNOVA's charges for workforce reductions,
consolidation of manufacturing facilities, sales and field service offices as
well as inventory and warranty adjustments. During the third quarter of 2000,
Unitrin recorded an after-tax gain of $4.2 million for its proportionate share
of UNOVA's gain from the sale of a business less certain severance charges.

On June 20, 2000, the fair value of Unitrin's investment in UNOVA declined below
Unitrin's carrying value of its investment in UNOVA. During the third quarter of
2000, Unitrin determined that the decline in the fair value of its investment in
UNOVA was other than temporary under applicable accounting standards.
Accordingly, Unitrin recorded an after-tax loss of $60.7 million to reduce the
carrying value of its investment in UNOVA to its then current estimated
realizable value. The loss has been allocated to Unitrin's proportionate share
of UNOVA's non-current assets. Accordingly, Unitrin's reported equity in the net
income of UNOVA differs from Unitrin's proportionate share of UNOVA's reported
results to the extent that such results include depreciation, amortization or
other charges related to such non-current assets.

In April 2001, Northrop Grumman Corporation ("Northrop") completed its
acquisition of Litton. Prior to the Northrop-Litton transaction, Unitrin and its
subsidiaries owned approximately 12.7 million shares or 28% of Litton's
outstanding common stock. Unitrin and its subsidiaries tendered all of their
shares of Litton common stock to Northrop. In exchange for its holdings of
Litton common stock, Unitrin and its subsidiaries received approximately 1.8
million shares of Northrop Series B convertible preferred stock and
approximately 7.7 million shares of Northrop common stock in a tax-free
exchange. In addition to receiving the Northrop preferred and common stock,
Unitrin and its subsidiaries received cash of $171.8 million, net of transaction
costs. In the second quarter of 2001, the Company recognized a pre-tax
accounting gain of $562.1 million and an after-tax accounting gain of $362.4
million, or $5.37 per common share related to this transaction.

5
Note 3 - Investment in Investees (continued)

Prior to Northrop's acquisition of Litton, Unitrin accounted for its investment
in Litton under the equity method of accounting. As a result of the
Northrop-Litton transaction, Unitrin's ownership percentage in the combined
company fell below 20%, and accordingly, Unitrin does not apply the equity
method of accounting to its investments in Northrop. For the year ended December
31, 2000, Unitrin recorded net income of $38.2 million, or $0.56 per common
share, from its investment in Litton. Depending on a number of factors,
including Northrop continuing to pay dividends on its common stock at its
current rate and the reinvestment of the net cash proceeds from the transaction,
Unitrin expects that its ongoing, annual reported net income will decrease by
approximately $12.2 million as a result of this transaction, but expects that
its annual after-tax cash flow will increase by approximately $26.0 million.
Since Litton did not pay dividends on its common stock, Unitrin's annual
after-tax cash flow from its investment in Litton was zero. The terms of the
preferred stock provide for the payment of dividends, and Northrop also
currently pays dividends on its common stock.

Unitrin and Curtiss-Wright are parties to an agreement providing for the
spin-off of Unitrin's equity ownership interest in Curtiss-Wright in a tax-free
distribution to Unitrin's shareholders. In connection with the spin-off, all of
the 4.4 million Curtiss-Wright shares currently held by Unitrin will be
exchanged for 4.4 million shares of a new Class B common stock of Curtiss-Wright
that will be entitled to elect at least 80% of the Board of Directors of
Curtiss-Wright but will otherwise be substantially identical to Curtiss-Wright's
existing common stock. The Curtiss-Wright Class B common stock will be
immediately distributed pro ratably to shareholders of Unitrin. All of the other
outstanding shares of Curtiss-Wright common stock will remain outstanding and be
entitled to elect approximately 20% of the Board of Directors of Curtiss-Wright.
The recapitalization and spin-off have been approved by both the Unitrin and
Curtiss-Wright Boards of Directors. The exchange will be part of a
Curtiss-Wright recapitalization and requires approval by Curtiss-Wright
shareholders other than Unitrin. Curtiss-Wright is scheduled to hold a special
meeting of its shareholders on October 26, 2001 to vote on the recapitalization
and certain other matters.

On July 12, 2001, three of Unitrin's subsidiaries entered into a financing
agreement whereby the subsidiaries and other unrelated parties became
participants in a $75 million three-year term loan agreement with UNOVA. Under
the agreement, the subsidiaries provided $31.5 million in funding to UNOVA.

In the third quarter of 2001, two of Unitrin's subsidiaries purchased a portion
of UNOVA's outstanding publicly-traded Notes maturing in March 2005 with a total
par value of $5.0 million.

Note 4 - Securities Lending

On May 16, 2001, two of the Company's subsidiaries entered into a securities
lending agreement with the Bank of New York ("BNY") whereby BNY was appointed to
act as agent to lend securities in the subsidiaries' accounts to unrelated
parties, primarily large brokerage firms. Borrowers of these securities must
deposit cash collateral with the subsidiaries equal to 102% of the fair value of
the securities loaned. The subsidiaries continue to receive the interest on
loaned securities as beneficial owners, and accordingly, the loaned securities
are included in Fixed Maturities. The amount of collateral received is invested
in short-term securities, and is included in these financial statements as
Short-term Investments with a corresponding Liability for Funds Held for
Securities on Loan included in Accrued Expenses and Other Liabilities. At
September 30, 2001, the fair value of collateral held was $234.2 million.

6
Note 5 - Notes Payable

The Company has borrowing capacity of $440 million under an unsecured revolving
credit agreement, expiring September 2002, with a group of banks that provides
for fixed and floating rate advances for periods of up to 180 days at various
interest rates. The agreement contains various financial covenants, including
limits on total debt to total capitalization and minimum risk-based capital
ratios for the Company's direct insurance subsidiaries. The proceeds from
advances under the revolving credit agreement may be used for general corporate
purposes, including repurchases of the Company's common stock.

At September 30, 2001 and December 31, 2000, the Company had outstanding
borrowings under the revolving credit agreement of $207 million and $179
million, respectively, at weighted average interest rates of 3.57% and 6.76%,
respectively. Interest expense under the revolving credit agreement was $7.2
million and $10.3 million for the nine months ended September 30, 2001 and 2000,
respectively. Interest expense under the revolving credit agreement was $2.1
million and $4.0 million for the three months ended September 30, 2001 and 2000,
respectively.

Note 6 - TenFold Dispute

In 1997, a subsidiary of the Company entered into an agreement with TenFold
Corporation ("TenFold") to develop an integrated software application
("PowerPAC") for Unitrin's Multi Lines Insurance segment. Under the terms of the
agreement, as amended, TenFold was required to complete and deliver a PowerPAC
system that satisfied all contractual requirements by September 1, 2000. TenFold
did not deliver PowerPAC by the required deadline. The Company notified TenFold
on September 14, 2000 that it considered TenFold to be in material breach of the
agreement and, pursuant to its express terms, requested that TenFold refund to
the Company all amounts it had paid to TenFold for the PowerPAC project. The
dispute was submitted to arbitration and, on March 8, 2001, the Company and
TenFold entered in a confidential agreement whereby the parties, in exchange for
a payment from TenFold's insurer to the Company, settled the dispute. The
difference between such recovery and the amount previously estimated as
recoverable in the Company's financial statements was not material.

Interest and Other Expenses for the nine and three months ended September 30,
2000 includes a $12.3 million before tax charge primarily to write-off payroll
costs related to the PowerPAC project previously capitalized under Statement of
Position ("SOP") No. 98-1, "Accounting for the Costs of Computer Software
Developed or Obtained for Internal Use".

Note 7 - Other Comprehensive Income

Other Comprehensive Income related to the Company's Investments for the nine and
three months ended September 30, 2001 and 2000 was:

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
-------------------- ---------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
------------------------------------------------------------------ ---------- --------- ---------- ---------
<S> <C> <C> <C> <C>
Increase in Unrealized Gains, Net of
Reclassification Adjustment for Gains Included in Net Income $ 142.0 $ 120.7 $ 204.7 $ 52.2
Equity In Other Comprehensive Loss of Investees (0.2) (4.7) (1.1) (2.0)
Effect of Income Taxes (49.7) (40.7) (71.6) (17.5)
--------- -------- --------- ---------
Other Comprehensive Income $ 92.1 $ 75.3 $ 132.0 $ 32.7
========= ======== ========= =========
</TABLE>


The Company's Investments in Investees are accounted for under the equity method
of accounting and, accordingly, changes in the fair value of the Company's
Investments in Investees are excluded from the determination of Total
Comprehensive Income and Other Comprehensive Income under SFAS No. 130
"Reporting Comprehensive Income". Total Comprehensive Income for the nine months
ended September 30, 2001 and 2000 was $485.1 million and $138.4 million,
respectively. Total Comprehensive Income for the three months ended September
30, 2001 and 2000 was $152.1 million and $28.4 million, respectively.

7
Note 8 - Business Segments

The Company is engaged, through its subsidiaries, in the property and casualty
insurance, life and health insurance and consumer finance businesses. The
Company conducts its operations through five operating segments: Multi Lines
Insurance, Specialty Lines Insurance, Life and Health Insurance, Consumer
Finance and Unitrin Direct. Insurance products provided by the Multi Lines
Insurance segment consist of preferred and standard risk automobile,
homeowners, fire, commercial liability and workers compensation. Multi Lines
Insurance products are marketed to individuals and businesses with favorable
risk characteristics and loss histories and are sold by independent insurance
agents. Specialty Lines Insurance products consist of automobile, motorcycle and
watercraft insurance sold to individuals and businesses in the non-standard and
specialty market through independent agents. The non-standard automobile
insurance market consists of individuals and companies that have difficulty
obtaining standard or preferred risk insurance because of their driving records.
The Life and Health Insurance segment includes individual life, accident, health
and hospitalization insurance sold primarily by employee-agents. The Life and
Health Insurance segment also includes property insurance products sold by its
employee-agents. The Consumer Finance segment makes consumer loans primarily for
the purchase of used automobiles and offers thrift products in the form of
investment certificates and savings accounts. Unitrin Direct provides personal
automobile insurance marketed through direct mail, radio and television
advertising and over the Internet.

It is the Company's management practice to allocate certain corporate expenses
to its operating units. The Company considers the management of its investments
in its Investees and certain other investments, primarily Northrop common and
preferred stock and Baker Hughes common stock, to be a corporate responsibility
and excludes income from these investments from its Operating Segments.

8
Note 8 - Business Segments (continued)

Segment Revenues and Operating Profit (Loss) for the nine and three months ended
September 30, 2001 and 2000 were:

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
-------------------------- ------------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
---------------------------------------------------------- ----------- ---------- ---------- ----------
<S> <C> <C> <C> <C>
Revenues:
Multi Lines Insurance:
Premiums $ 427.2 $ 408.4 $ 148.4 $ 142.4
Net Investment Income 31.9 34.2 10.3 12.5
----------- ---------- ---------- ----------
Total Multi Lines Insurance 459.1 442.6 158.7 154.9
----------- ---------- ---------- ----------

Specialty Lines Insurance:
Premiums 248.4 153.6 93.5 56.1
Net Investment Income 10.8 10.7 3.9 4.1
----------- ---------- ---------- ----------
Total Specialty Lines Insurance 259.2 164.3 97.4 60.2
----------- ---------- ---------- ----------

Life and Health Insurance:
Premiums 480.0 521.8 160.2 165.4
Net Investment Income 135.4 135.4 44.3 47.0
----------- ---------- ---------- ----------
Total Life and Health Insurance 615.4 657.2 204.5 212.4
----------- ---------- ---------- ----------

Consumer Finance 119.0 103.9 40.7 36.3
----------- ---------- ---------- ----------

Unitrin Direct 5.0 - 3.3 -
----------- ---------- ---------- ----------
Total Segment Revenues 1,457.7 1,368.0 504.6 463.8
----------- ---------- ---------- ----------

Dividend Income from Corporate Investments 10.5 3.5 6.6 0.5
Net Gains on Sales of Investments 563.8 133.2 1.2 37.8
Other (11.6) (16.3) (3.8) (6.0)
----------- ---------- ---------- ----------
Total Revenues $ 2,020.4 $ 1,488.4 $ 508.6 $ 496.1
=========== ========== ========== ==========

Segment Operating Profit (Loss):
Multi Lines Insurance $ (42.9) $ (19.7) $ (19.2) $ (2.2)
Specialty Lines Insurance (12.9) (1.0) (0.6) 1.4
Life and Health Insurance 73.9 34.1 28.7 37.5
Consumer Finance 22.6 18.9 9.2 6.5
Unitrin Direct (15.6) (3.9) (5.2) (2.3)
----------- ---------- ---------- ----------
Total Segment Operating Profit 25.1 28.4 12.9 40.9
----------- ---------- ---------- ----------

Dividend Income from Corporate Investments 10.5 3.5 6.6 0.5
Net Gains on Sales of Investments 563.8 133.2 1.2 37.8
Other Expense, Net (18.0) (40.4) (5.6) (22.4)
----------- ---------- ---------- ----------

Income Before Income Taxes and
Equity in Net Income (Loss) of
Investees $ 581.4 $ 124.7 $ 15.1 $ 56.8
=========== ========== ========== ==========
</TABLE>

9
Note 9 - Legal Proceedings and Other Regulatory Matters

In October 1999, the Florida Department of Insurance filed and served a subpoena
upon the Company's subsidiary, United Insurance Company of America ("United"),
in connection with that Department's investigation into the sale and servicing
of industrial life insurance and small face amount life insurance policies in
the State of Florida. Subsequently, on December 15, 1999, a purported nationwide
class action lawsuit was filed against United in the United States District
Court for the Middle District of Florida (Wilson, et al. v. United Insurance
Company of America), on behalf of "all African-American persons who have (or
have had at the time of the Policy's termination), an ownership interest in one
or more Industrial Life Insurance Policies issued, serviced, administered or
purchased from United...." Plaintiffs allege discrimination in premium rates in
violation of 42 U.S.C. 1981 in addition to various state law claims. Unspecified
compensatory and punitive damages are sought together with equitable relief. The
Company has determined that United and its other career agency life insurance
subsidiaries have in force insurance policies in which race was used as an
underwriting factor in pricing or benefits; however, to the best of the
Company's knowledge, all such practices ceased 30 or more years ago with regard
to newly-issued policies. At least twenty similar lawsuits have been filed in
other jurisdictions against the Company and/or its career agency life insurance
subsidiaries. The Judicial Panel on Multi-District Litigation has ordered that
substantially all of these lawsuits be consolidated for pretrial purposes in the
United States District Court for the Eastern District of Louisiana. The Company
believes that it and its subsidiaries have meritorious defenses in these
matters; nonetheless, the Company continues to engage in settlement discussions
with plaintiffs' counsel and representatives of various insurance departments.
On July 17, 2000 the Florida Department of Insurance issued orders to more than
two dozen life insurers, including United and the Company's other career agency
subsidiaries, to cease collecting a portion of the premiums on certain
industrial life policies attributable to past race-distinct underwriting
practices. These subsidiaries appealed the orders directed at them and, in
September of 2001, a Florida appellate court ruled that the orders had been
improperly issued. In the second quarter of 2000, the Company recorded an
after-tax charge of $32.4 million for its estimated cost to ultimately settle
these matters. Actual costs may differ from this estimate. However, the Company
believes that such difference will not have a material adverse effect on the
Company's financial position, but could have a material adverse effect on the
Company's results for a given period.

The Company and its subsidiaries are defendants in various other legal actions
incidental to their businesses; some of which seek substantial punitive damages
that bear no apparent relationship to the actual damages alleged. The plaintiffs
in certain of these suits seek class action status which, if granted, could
expose the Company and its subsidiaries to potentially significant liability by
virtue of the size of the purported classes. In addition, the State of
Mississippi, where the Company and some of its subsidiaries are defendants in a
number of lawsuits, has recently received national attention for a large number
of multi-million dollar jury verdicts and settlements against corporations in a
variety of industries. Although Mississippi law does not permit class actions,
recent case law there allows for virtually unlimited joinder of plaintiffs in a
single action, thereby simulating a class action lawsuit. Although the Company
and its subsidiaries believe that there are meritorious defenses to the cases
referenced in this paragraph and are defending them vigorously, and although the
Company believes that resolution of these cases will not have a material adverse
effect on the Company's financial position, there can be no assurance that one
or more of these cases will not produce significant jury awards which could have
a material adverse effect on the Company's results for any given period.

10
Item 2. Management's Discussion and Analysis of Results of Operations and
Financial Condition

Multi Lines Insurance

<TABLE>
<CAPTION>

Nine Months Ended Three Months Ended
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Milllions) 2001 2000 2001 2000
------------------------------------------------ ----------- --------- ---------- ---------
<S> <C> <C> <C> <C>
Premiums:
Personal Lines:
Personal Automobile $ 148.7 $ 148.9 $ 49.6 $ 50.3
Homeowners 52.7 53.0 17.7 18.0
Other 7.9 7.5 2.6 2.6
----------- --------- ---------- ---------
Total Personal Lines 209.3 209.4 69.9 70.9
----------- --------- ---------- ---------
Commercial Lines:
Commercial Property & Liability 97.4 98.8 35.1 33.3
Commercial Automobile 80.3 60.1 28.5 22.7
Other 40.2 40.1 14.9 15.5
----------- --------- ---------- ---------
Total Commercial Lines 217.9 199.0 78.5 71.5
----------- --------- ---------- ---------
Total Premiums 427.2 408.4 148.4 142.4
----------- --------- ---------- ---------
Net Investment Income 31.9 34.2 10.3 12.5
----------- --------- ---------- ---------
Total Revenues $ 459.1 $ 442.6 $ 158.7 $ 154.9
----------- --------- ---------- ---------
Operating Profit (Loss) $ (42.9) $ (19.7) $ (19.2) $ (2.2)
=========== ========= ========== =========
GAAP Incurred Loss Ratio (excluding Storms) 72.5% 67.5% 76.1% 67.8%
GAAP Incurred Storm Ratio 14.6% 13.6% 12.5% 11.6%
Total GAAP Incurred Loss Ratio 87.1% 81.1% 88.6% 79.4%
GAAP Combined Ratio 117.5% 113.2% 121.9% 110.4%
</TABLE>

Premiums in the Multi Lines Insurance segment increased by $18.8 million and
$6.0 million for the nine and three months ended September 30, 2001,
respectively, compared to the same periods in 2000 due primarily to higher
premium rates, partially offset by lower volume. Net Investment Income decreased
$2.3 million and $2.2 million for the nine and three months ended September 30,
2001, respectively, compared to the same periods last year due to lower levels
of investments and lower yields on investments. Operating Loss in the Multi
Lines Insurance segment increased by $23.2 million and $17.0 million for the
nine and three months ended September 30, 2001, respectively, compared to the
same periods last year.

Operating results for the nine months ended September 30, 2001 reflect increased
Operating Loss in both commercial lines and personal lines resulting from
increased storm losses, large losses (individual losses estimated to be in
excess of $100 thousand) and the effects of adverse reserve development
partially due to increased severity. Reserve development, which reflects changes
in estimates of prior period reserves in the current period, had an adverse
effect of $11.6 million for the nine months ended September 30, 2001, compared
to an adverse impact of $2.6 million for the same period in 2000. Storm losses
were $62.2 million for the nine months ended September 30, 2001, an increase of
$6.5 million compared to the same period in 2000. Large losses were $32.7
million for the nine months ended September 30, 2001, an increase of $12.8
million when compared to the same period in 2000.

Operating results for the three months ended September 30, 2001 reflect
increased Operating Loss in both commercial lines and personal lines resulting
from increased storm losses, large losses and the effects of adverse reserve
development partially due to increased severity. Reserve development had an
adverse effect of $6.0 million for the three months ended September 30, 2001,
compared to an adverse impact of $3.1 million for the same period in 2000. Storm
losses were $18.6 million for the three months ended September 30, 2001, an
increase of $2.0 million compared to the same period in 2000. Large losses were
$14.0 million for the three months ended September 30, 2001, an increase of $4.3
million compared to the same period in 2000. There were no reported losses in
the Multi Lines Insurance segment related to the terrorist attacks on September
11, 2001.

The Company is continuing to implement certain premium rate increases in most
product lines, subject to regulatory approvals where applicable. The Company is
also continuing to review underwriting guidelines in certain markets and product
lines and continues to implement certain underwriting changes as it writes and
renews its business, including placing a moratorium on new business in certain
markets where adequate rates cannot be obtained.

11
Specialty Lines Insurance

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
------------------------ -----------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
------------------------------------------------- ---------- ---------- --------- ----------
<S> <C> <C> <C> <C>
Premiums:
Personal Automobile $ 229.2 $ 136.6 $ 86.6 $ 50.4
Commercial Automobile 16.9 14.9 6.2 5.0
Other 2.3 2.1 0.7 0.7
---------- --------- -------- ----------
Total Premiums 248.4 153.6 93.5 56.1
---------- --------- -------- ----------
Net Investment Income 10.8 10.7 3.9 4.1
---------- --------- -------- ----------
Total Revenues $ 259.2 $ 164.3 $ 97.4 $ 60.2
========== ========= ======== ==========

Operating Profit (Loss) $ (12.9) $ (1.0) $ (0.6) $ 1.4
========== ========= ======== ==========

GAAP Incurred Loss Ratio (excluding Storms) 80.5% 77.7% 80.4% 76.6%
GAAP Incurred Storm Ratio 2.8% 1.0% -1.2% 0.5%
Total GAAP Incurred Loss Ratio 83.3% 78.7% 79.2% 77.1%
GAAP Combined Ratio 109.5% 107.6% 104.8% 104.7%
</TABLE>

Premiums in the Specialty Lines Insurance segment increased by $94.8 million and
$37.4 million for the nine and three months ended September 30, 2001,
respectively, compared to the same periods in 2000 due to higher premium volume
and premium rates. Operating Loss in the Specialty Lines Insurance segment
increased by $11.9 million and $2.0 million for the nine and three months ended
September 30, 2001, respectively, compared to the same periods last year.

Operating results for the nine months ended September 30, 2001 reflect increased
Operating Loss in personal lines due primarily to increased losses, including
storm losses, which more than offset premium increases. Storm losses were $ 6.8
million for the nine months ended September 30, 2001, an increase of $5.3
million compared to the same period last year. Operating results for the three
months ended September 30, 2001 reflect increased Operating Loss in personal
lines resulting from higher losses, which more than offset premium increases. In
the third quarter of 2001, the Company reduced its estimate of storm losses
previously recorded in the second quarter of 2001 by $1.1 million. Storm losses
were $0.3 million for the three months ended September 30, 2000. There were no
reported losses in the Specialty Lines Insurance segment related to the
terrorist attacks on September 11, 2001.

The Company is continuing to implement certain premium rate increases in most
states and product lines, subject to regulatory approvals where applicable. The
Company is also continuing to review underwriting guidelines in certain markets
and product lines and continues to implement certain underwriting changes as it
writes and renews its business.

12
Life and Health Insurance

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
------------------------ ------------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
--------------------------------------------------------- ---------- --------- --------- ---------
<S> <C> <C> <C> <C>
Premiums:
Life $ 301.1 $ 305.9 $ 100.1 $ 100.9
Accident and Health 113.4 152.0 37.9 42.9
Property 65.5 63.9 22.2 21.6
--------- --------- --------- ---------
Total Premiums 480.0 521.8 160.2 165.4
Net Investment Income 135.4 135.4 44.3 47.0
--------- --------- --------- ---------
Total Revenues $ 615.4 $ 657.2 $ 204.5 $ 212.4
========= ========= ========= =========

Operating Profit $ 73.9 $ 34.1 $ 28.7 $ 37.5
========= ========= ========= =========
</TABLE>

Premiums in the Life and Health Insurance segment decreased by $41.8 million and
$5.2 million for the nine and three months ended September 30, 2001, compared to
the same periods in 2000 due primarily to the July 2000 sale of The Pyramid Life
Insurance Company. Pyramid recorded accident and health insurance premiums of
$34.5 million and $4.3 million and life insurance premiums of $3.2 million and
$0.5 million for the nine and three months ended September 30, 2000,
respectively. Excluding the effects of the sale of Pyramid, premiums decreased
due primarily to lower volume of life insurance and accident and health
insurance, partially offset by higher accident and health insurance premium
rates and higher volume of property insurance sold by the Life and Health
Insurance segment's career agents.

Net Investment Income was unchanged for the nine months ended September 30,
2001, compared to the same period in 2000 as a higher level of investments was
offset by lower yields. Net Investment Income decreased by $2.7 million for the
three months ended September 30, 2001, compared to the same period in 2000, as
lower investment yields were partially offset by a higher level of investments.

Operating Profit in the Life and Health Insurance segment increased by $39.8
million for the nine months ended September 30, 2001, compared to the same
period in 2000. Results for the Life and Health Insurance segment included a
charge of $48.8 million in the second quarter of 2000 for the Company's estimate
of the cost to ultimately settle certain matters (See Note 9 to the Condensed
Consolidated Financial Statements). Excluding the effects of the charge in 2000,
Operating Profit for the nine months ended September 30, 2001, decreased by $9.0
million compared to the same period in 2000 due primarily to higher benefits and
expenses as a percent of premiums for life and accident and health insurance,
partially offset by improved results from property insurance sold by the Life
and Health Insurance segment's career agents. Operating Profit decreased $8.8
million for the three months ended September 30, 2001, compared to the same
period in 2000, due primarily to the lower Net Investment Income and higher
benefits and expenses as a percent of premiums for life and accident and health
insurance, partially offset by improved results from property insurance sold by
the Life and Health Insurance segment's career agents. There were no reported
losses in the Life and Health Insurance segment related to the terrorist attacks
on September 11, 2001.

13
Consumer Finance

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
----------------- ------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
---------------------------------------------------------------------- ---------- --------- --------- ---------
<S> <C> <C> <C> <C>
Interest, Loan Fees and Earned Discount $ 109.2 $ 95.3 $ 37.4 $ 32.9
Net Investment Income 6.6 5.9 2.0 2.4
Other 3.2 2.7 1.3 1.0
---------- --------- --------- ---------
Total Revenues 119.0 103.9 40.7 36.3
---------- --------- --------- ---------
Provision for Losses on Consumer Finance Receivables 22.2 20.3 6.9 6.9
Interest Expense on Investment Certificates and Savings Accounts 33.4 28.2 10.8 10.4
General and Administrative Expenses 40.8 36.5 13.8 12.5
---------- --------- --------- ---------
Operating Profit $ 22.6 $ 18.9 $ 9.2 $ 6.5
========== ========= ========= =========

Consumer Finance Loan Originations $ 367.3 $ 355.9 $ 111.6 $ 120.5
Percentage of Consumer Finance Receivables
Greater than Ninety Days Past Due 0.6% 0.5% 0.6% 0.5%
Ratio of Reserve for Loan Losses on Consumer Finance Receivables
to Gross Consumer Finance Receivables 5.0 5.2 5.0 5.2
Weighted-Average Interest Rates Paid on
Investment Certificates and Savings Accounts 6.0% 5.8% 5.6% 6.1%
</TABLE>

Revenues in the Consumer Finance segment increased by $15.1 million and $4.4
million for the nine and three months ended September 30, 2001, respectively,
compared to the same periods in 2000, due primarily to a higher level of loans
outstanding. Operating Profit in the Consumer Finance segment increased by $3.7
million and $2.7 million for the nine and three months ended September 30, 2001,
respectively, compared to the same periods in 2000 due primarily to the higher
level of loans outstanding. Provision for Losses on Consumer Finance Receivables
increased $1.9 million for the nine months ended September 30, 2001, compared to
the same period in 2000, due primarily to a higher level of consumer finance
loans outstanding. Interest Expense on Investment Certificates and Savings
Accounts increased by $5.2 million for the nine months ended September 30, 2001,
compared to the same period in 2000 due primarily to higher levels of Investment
Certificates and Savings Accounts. Interest Expense on Investment Certificates
and Savings Accounts increased by $0.4 million for the three months ended
September 30, 2001, compared to the same period in 2000 due to higher levels of
Investment Certificates and Savings Accounts, partially offset by lower interest
rates on Investment Certificates and Savings Accounts. General and
Administrative Expenses, as a percentage of Consumer Finance Revenues, decreased
from 35.1% and 34.4% for the nine and three months ended September 30, 2000,
respectively, to 34.3% and 33.9% for the nine and three months ended September
30, 2001, respectively, due primarily to the higher levels of loans outstanding.

Consumer Finance Loan Originations decreased in the third quarter of 2001,
compared to both the third quarter of 2000 and the second quarter of 2001. The
Company believes that the decrease in Consumer Finance Loan Originations is
partially attributable to the impact that the events of September 11,
2001 have had on the economy.

14
Unitrin Direct

On January 3, 2000, the Company established Unitrin Direct, a direct marketing
automobile insurance unit, to market personal automobile insurance through
direct mail, radio and television advertising and the Internet. The business
unit primarily utilizes the Company's wholly-owned subsidiary, Unitrin Direct
Insurance Company, but may also utilize the licenses of other Unitrin
subsidiaries as needed in states in which it is not currently licensed. Unitrin
Direct is managed and reported as a separate business segment. In January 2001,
Unitrin Direct began actively marketing personal automobile insurance in the
state of Pennsylvania. Unitrin Direct then entered Florida in May 2001 and
Michigan in September 2001. Several additional states are planned for
introduction in 2002, subject to regulatory approvals.

Premiums written for the nine and three months ended September 30, 2001 were
$16.0 million and $7.9 million, respectively. Premiums earned for the nine and
three months ended September 30, 2001 were $5.0 million and $3.3 million,
respectively. For the nine and three months ended September 30, 2001, Unitrin
Direct recorded Operating Loss of $15.6 million and $5.2 million, respectively,
compared to Operating Loss of $3.9 million and $2.3 million, respectively, for
the same periods in 2000, due primarily to upfront marketing expenses and other
start-up costs necessary to build economies of scale. While key metrics for
Unitrin Direct are still developing, its first nine months of results are
primarily meeting or exceeding the Company's expectations. These metrics include
mix of business, conversion ratios (number of quotes that become sold policies),
acquisition cost per sale, average premiums, claim frequencies and loss ratios.
There were no reported losses in the Unitrin Direct segment related to the
terrorist attacks on September 11, 2001.

Building a direct marketing insurer requires a significant investment resulting
in up-front costs and expenses. Accordingly, the Company expects that Unitrin
Direct will produce operating losses for at least the next few years.

Equity in Net Income(Loss) of Investees

Equity in Net Income(Loss) of Investees was income of $16.2 million and $9.1
million for the nine and three months ended September 30, 2001, respectively,
compared to a loss of $17.8 million and $42.5 million for the nine and three
months ended September 30, 2000, respectively. Equity in Net Income(Loss) of
Investees for each of the Company's investee companies for the nine and three
months ended September 30, 2001 and 2000 was:

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
------------------------------ -------------------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
-------------------------------------- ------------- ------------- ------------- --------------
<S> <C> <C> <C> <C>
Curtiss-Wright Corporation $ 8.7 $ 8.4 $ 3.1 $ 3.2
Litton Industries, Inc. 8.8 30.2 - 12.6
UNOVA, Inc. (1.3) (56.4) 6.0 (58.3)
------------- ------------- ------------- --------------
Equity In Net Income (Loss) of Investees $ 16.2 $ (17.8) $ 9.1 $ (42.5)
============= ============= ============= ==============
</TABLE>


Unitrin's proportionate share of UNOVA's results for both the nine and three
months ended September 30, 2001 includes an after tax gain of $5.3 million as a
result of UNOVA's completion of a partial settlement of its defined benefit
pension obligations through the purchase of annuity contracts. Unitrin's
proportionate share of UNOVA's results for the nine and three months ended
September 30, 2001, also includes after-tax losses of $ 3.2 million and $0.4
million, respectively, related to UNOVA's charges for workforce reductions,
consolidation of manufacturing facilities, sales and field service offices as
well as inventory and warranty adjustments. During the third quarter of 2000,
Unitrin recorded an after-tax gain of $4.2 million for its proportionate share
of UNOVA's gain from the sale of a business less certain severance charges.

On June 20, 2000, the fair value of Unitrin's investment in UNOVA declined below
Unitrin's carrying value of its investment in UNOVA. During the third quarter of
2000, Unitrin determined that the decline in the fair value of its investment in
UNOVA was other than temporary under applicable accounting standards.
Accordingly, Unitrin recorded an after-tax loss of $60.7 million to reduce the
carrying value of its investment in UNOVA to its then current estimated
realizable value. The loss has been allocated to Unitrin's proportionate share
of UNOVA's non-current assets. Accordingly, Unitrin's reported equity in the net
income of UNOVA differs from Unitrin's proportionate share of UNOVA's reported
results to the extent that such results include depreciation, amortization or
other charges related to such non-current assets.


15
In April 2001, Northrop Grumman Corporation ("Northrop") completed its
acquisition of Litton. Prior to the Northrop-Litton transaction, Unitrin and its
subsidiaries owned approximately 12.7 million shares or 28% of Litton's
outstanding common stock. Unitrin and its subsidiaries tendered all of their
shares of Litton common stock to Northrop. In exchange for its holdings of
Litton common stock, Unitrin and its subsidiaries received approximately 1.8
million shares of Northrop Series B convertible preferred stock and
approximately 7.7 million shares of Northrop common stock in a tax-free
exchange. In addition to receiving the Northrop preferred and common stock,
Unitrin and its subsidiaries received cash of $171.8 million, net of transaction
costs. In the second quarter of 2001, the Company recognized a pre-tax
accounting gain of $562.1 million and an after-tax accounting gain of $362.4
million, or $5.37 per common share related to this transaction.

Prior to Northrop's acquisition of Litton, Unitrin accounted for its investment
in Litton under the equity method of accounting. As a result of the
Northrop-Litton transaction, Unitrin's ownership percentage in the combined
company fell below 20%, and accordingly, Unitrin does not apply the equity
method of accounting to its investments in Northrop. For the year ended December
31, 2000, Unitrin recorded net income of $38.2 million, or $0.56 per common
share, from its investment in Litton. Depending on a number of factors,
including Northrop continuing to pay dividends on its common stock at its
current rate and the reinvestment of the net cash proceeds from the transaction,
Unitrin expects that its ongoing, annual reported net income will decrease by
approximately $12.2 million as a result of this transaction, but expects that
its annual after-tax cash flow will increase by approximately $26.0 million.
Since Litton did not pay dividends on its common stock, Unitrin's annual
after-tax cash flow from its investment in Litton was zero. The terms of the
preferred stock provide for the payment of dividends, and Northrop also
currently pays dividends on its common stock.

Unitrin and Curtiss-Wright are parties to an agreement providing for the
spin-off of Unitrin's equity ownership interest in Curtiss-Wright in a tax-free
distribution to Unitrin's shareholders. In connection with the spin-off, all of
the 4.4 million Curtiss-Wright shares currently held by Unitrin will be
exchanged for 4.4 million shares of a new Class B common stock of Curtiss-Wright
that will be entitled to elect at least 80% of the Board of Directors of
Curtiss-Wright but will otherwise be substantially identical to Curtiss-Wright's
existing common stock. The Curtiss-Wright Class B common stock will be
immediately distributed pro ratably to shareholders of Unitrin. All of the other
outstanding shares of Curtiss-Wright common stock will remain outstanding and be
entitled to elect approximately 20% of the Board of Directors of Curtiss-Wright.
The recapitalization and spin-off have been approved by both the Unitrin and
Curtiss-Wright Boards of Directors. The exchange will be part of a
Curtiss-Wright recapitalization and requires approval by Curtiss-Wright
shareholders other than Unitrin. Curtiss-Wright is scheduled to hold a special
meeting of its shareholders on October 26, 2001 to vote on the recapitalization
and certain other matters.

On July 12, 2001, three of Unitrin's subsidiaries entered into a financing
agreement whereby the subsidiaries and other unrelated parties became
participants in a $75 million three-year term loan agreement with UNOVA. Under
the agreement, the subsidiaries provided $31.5 million in funding to UNOVA.

In the third quarter of 2001, two of the Company's subsidiaries purchased a
portion of UNOVA's outstanding publicly-traded Notes maturing in March 2005 with
a total par value of $5.0 million.


16
Corporate Investments

The Company considers the management of certain investments, including Northrop
common and preferred stock and Baker Hughes common stock, to be a corporate
responsibility and excludes income from these investments from its Operating
Segments. Dividend income from these Corporate Investments was:

<TABLE>
<CAPTION>
Nine Months Ended Three Months Ended
----------------------------- -----------------------------
Sept. 30, Sept. 30, Sept. 30, Sept. 30,
(Dollars in Millions) 2001 2000 2001 2000
-------------------------------------------------------- ------------ ----------- ----------- -----------
<S> <C> <C> <C> <C>
Northrop common stock $ 6.1 $ - $ 3.1 $ -
Northrop preferred stock 3.1 - 3.1 -
Baker Hughes common stock 1.3 3.5 0.4 0.5
------------ ----------- ----------- ----------
Total Dividend Income on Corporate Investments $ 10.5 $ 3.5 $ 6.6 $ 0.5
============ =========== =========== ==========
</TABLE>



The Company received its shares of Northrop common and preferred stock as a
result of the acquisition of the Company's former investee, Litton Industries,
Inc., by Northrop Grumman Corporation (See Note 3 to the Condensed Consolidated
Financial Statements). The acquisition occurred in the second quarter of 2001
and, accordingly, the Company had no dividends from Northrop common or preferred
stock in 2000. In the second quarter of 2001, the Company did not record
dividend income on its investment in Northrop preferred stock due to the timing
of the ex-dividend date. The Company sold a portion of its Baker Hughes common
stock holdings in 2000 and the first three months of 2001. Accordingly, dividend
income from Baker Hughes common stock has decreased for the nine and three
months ended September 30, 2001, compared to the same periods last year. The
Company cannot anticipate when or if similar investment sales may occur in the
future.

Net Gains on Sales of Investments

Net Gains on Sales of Investments were $563.8 million and $1.2 million for the
nine and three months ended September 30, 2001, respectively, compared to $133.2
million and $37.8 million, respectively, for the same periods in 2000. Net Gains
on Sales of Investments for the nine months ended September 30, 2001 included a
pre-tax gain of $562.1 million resulting from the acquisition of Litton by
Northrop - See discussion above under the heading "Equity in Net Income (Loss)
of Investees." Net Gains on Sales of Investments for the nine and three months
ended September 30, 2000 included pre-tax gains of $125.4 million and $33.5
million, respectively, resulting from sales of a portion of the Company's
investment in Baker Hughes common stock. The Company cannot anticipate when or
if similar investment gains or losses may occur in the future.

Other Items

Other Expense, Net decreased by $22.4 million and $16.8 million for nine and
three months ended September 30, 2001, respectively, compared to the same
periods in 2000. Other Expense, Net for the nine and three months ended
September 30, 2000 includes a charge of $12.3 million to write-down the carrying
value of certain internal use software. Other Expense, Net includes interest
expense under the Company's revolving credit agreement of $7.2 million and $2.1
million for the nine and three months ended September 30, 2001, respectively,
compared to $10.3 million and $4.0 million, respectively, for the same periods
in 2000.

During the first nine months of 2001, the Company repurchased 708,700 shares of
its common stock in open market transactions at an aggregate cost of $ 26.0
million. The repurchases were made with general corporate funds. At September
30, 2001, the Company had approximately 3.9 million shares remaining under the
existing repurchase authorization.

At September 30, 2001, the unused commitment under the Company's revolving
credit facility was $ 233 million. In addition, for the remainder of 2001, the
Company's subsidiaries would be able to pay approximately $99 million in
dividends to the Company without prior regulatory approval.


17
Accounting Changes

In July 2001, the Financial Accounting Standards Board ("FASB") issued Statement
of Financial Accounting Standards "SFAS" No. 141 "Business Combinations". SFAS
No. 141 requires that all business combinations be accounted for under the
purchase method of accounting. SFAS No. 141 also changes the criteria for the
separate recognition of intangible assets acquired in a business combination.
SFAS No. 141 is effective for all business combinations initiated after June 30,
2001.

In July 2001, the FASB issued SFAS No. 142, "Goodwill and Other Intangible
Assets". SFAS No. 142 addresses accounting and reporting for intangible assets
acquired, except for those acquired in a business combination. SFAS No. 142
presumes that goodwill and certain intangible assets have indefinite useful
lifes. Accordingly, goodwill and certain intangibles will not be amortized but
rather will be tested at least annually for impairment. SFAS No. 142 also
addresses accounting and reporting for goodwill and other intangible assets
subsequent to their acquisition. SFAS No. 142 is effective for fiscal years
beginning after December 15, 2001. For the nine months ended September 30, 2001
the Company recorded Goodwill Amortization of $6.5 million. Goodwill was $346.8
million at September 30, 2001. The Company has not yet completed its assessment
of the impact of SFAS No. 142 on its financial statements.

In August 2001, the FASB issued SFAS No. 143, "Accounting for Asset Retirement
Obligations". This Statement addresses financial accounting and reporting for
obligations associated with the retirement of tangible long-lived assets and the
associated asset retirement costs. This Statement applies to all entities. It
applies to legal obligations associated with the retirement of long-lived assets
that result from the acquisition, construction, development and (or) the normal
operation of a long-lived asset, except for certain obligations of lessees. This
Statement also amends SFAS No. 19, "Financial Accounting and Reporting by Oil
and Gas Producing Companies". SFAS No. 143 is effective for financial statements
issued for fiscal years beginning after June 15, 2002. The Company expects that
the initial application of SFAS No. 143 will not have an impact on its
financial statements.

In October 2001, the FASB issued SFAS No. 144, "Accounting for the Impairment or
Disposal of Long-Lived Assets". SFAS No. 144 replaces SFAS No. 121, "Accounting
for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed
Of". The statement is intended to develop one accounting model, based on the
framework established in Statement 121, for long-lived assets to be disposed of
by sale and to address significant implementation issues. SFAS No.144 is
effective for financial statements issued for fiscal years beginning after
December 15, 2001, and interim periods within those fiscal years. The Company
expects that the initial application of SFAS No. 144 will not have an impact
on its financial statements.

In June 2000, the FASB issued SFAS No. 138, "Accounting for Certain Derivative
Instruments and Certain Hedging Activities--an amendment of FASB Statement
No.133." SFAS No. 138 addresses a limited number of implementation issues
related to SFAS No. 133 "Accounting for Derivatives Instruments and for Hedging
Activities." SFAS No. 133 requires all derivatives to be recorded on the balance
sheet at fair value and establishes "special accounting" for the following three
different types of hedges: hedges of changes in the fair value of assets,
liabilities or firm commitments; hedges of the variable cash flows of forecasted
transactions; and hedges of foreign currency exposures of net investments in
foreign operations. In June 1999, the FASB issued SFAS No. 137, "Accounting for
Derivative Instruments and Hedging Activities--Deferral of the Effective Date of
FASB Statement No. 133," which deferred the effective date of SFAS No. 133 to
years beginning after June 15, 2000, with earlier adoption permitted.
Accordingly, SFAS No. 133 is effective for years beginning after June 15, 2000,
with earlier adoption permitted. Effective January 1, 2001, the Company adopted
the provisions of SFAS Nos. 133 and 138. There was no effect of adoption on the
Company's financial statements.


18
Item 3. Quantitative and Qualitative Disclosure About Market Risk

Pursuant to the rules and regulations of the U.S. Securities and Exchange
Commission (the "SEC"), the Company is required to provide the following
disclosures about Market Risk.

Quantitative Information About Market Risk

The Company's condensed consolidated balance sheets include four types of
financial instruments subject to material risk disclosures required by the SEC:
(1) Investments in Fixed Maturities, (2) Investments in Equity Securities, (3)
Consumer Finance Receivables and (4) Investment Certificates and Savings
Accounts. Investments in Fixed Maturities, Consumer Finance Receivables and
Investment Certificates and Savings Accounts are subject to material interest
rate risk. The Company's Investment in Equity Securities include common and
preferred stocks and accordingly, are subject to material equity price risk and
interest rate risk, respectively.

For purposes of this disclosure, market risk sensitive financial instruments are
divided into two categories: financial instruments acquired for trading purposes
and financial instruments acquired for purposes other than trading. The
Company's market risk sensitive instruments are classified as held for purposes
other than trading. The Company has no holdings of derivative instruments.

The Company measures its sensitivity to market risk by evaluating the change in
its financial assets and liabilities relative to fluctuations in interest rates
and equity prices. The evaluation is made using instantaneous changes in
interest rates and equity prices on a static balance sheet to determine the
effect such changes would have on the Company's market value at risk and the
resulting pre-tax effect on Shareholders' Equity. The changes chosen reflect the
Company's view of adverse changes which are reasonably possible over a one-year
period. The selection of the changes chosen should not be construed as the
Company's prediction of future market events, but rather an illustration of the
impact of such events.

For the interest rate sensitivity analysis presented below, the Company assumed
an adverse and instantaneous increase of 100 basis points in market interest
rates for Investments in Fixed Maturities, Preferred Stock Equity Securities and
Consumer Finance Receivables from their levels at September 30, 2001 and
December 31, 2000, respectively, and an adverse and instantaneous decrease of
100 basis points in market interest rates for Investment Certificates and
Savings Accounts from their levels at September 30, 2001 and December 31, 2000,
respectively. All other variables were held constant. The Company measured
equity price sensitivity assuming an adverse and instantaneous 10% decrease in
the Standard and Poor's Stock Index (the "S&P 500") from its levels at September
30, 2001 and December 31, 2000, with all other variables held constant. The
Company's Investment in Common Stock Equity Securities were correlated with the
S&P 500 using the portfolio's weighted-average beta of 0.68 and 0.84 at
September 30, 2001 and December 31, 2000, respectively. The portfolio's
weighted-average beta was calculated using each security's beta for the
five-year periods ended September 30, 2001 and December 31, 2000, respectively
and weighted on the fair value of such securities at September 30, 2001 and
December 31, 2000, respectively. Beta measures a stock's relative volatility in
relation to the rest of the stock market with the S&P 500 having a beta
coefficient of 1.00.


19
The estimated adverse effects on the market value of the Company's financial
instruments using these assumptions was:

<TABLE>
<CAPTION>
---------------------------------------
Pro Forma Increase (Decrease)
--------------------------------------------------------------------------------------------------------------
Interest Equity Total Market
(Dollars in Millions) Fair Value Rate Risk Price Risk Risk
--------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
September 30, 2001
--------------------------------------------------------
Assets
Investments in Fixed Maturities $ 2,654.1 $ (92.6) $ - $ (92.6)
Investments in Equity Securities 1,361.1 (15.8) (61.9) (77.7)
Consumer Finance Receivables 726.1 (12.8) - (12.8)

Liabilities
Investment Certificates and Savings Accounts $ 752.2 $ 10.5 $ - $ 10.5

December 31, 2000
--------------------------------------------------------
Assets
Investments in Fixed Maturities $ 2,733.2 $ (99.0) $ - $ (99.0)
Investments in Equity Securities 367.8 (3.3) (23.7) (27.0)
Consumer Finance Receivables 677.8 (11.8) - (11.8)

Liabilities
Investment Certificates and Savings Accounts $ 698.6 $ 3.0 $ - $ 3.0
</TABLE>

The market risk sensitivity analysis assumes that the composition of the
Company's interest rate sensitive assets and liabilities, including but not
limited to future contractual cash flows and credit quality, and equity price
sensitive assets existing at the beginning of the period remains constant over
the period being measured. It also assumes that a particular change in interest
rates is reflected uniformly across the yield curve regardless of the time to
maturity. Interest rates on certain types of assets and liabilities may
fluctuate in advance of changes in market interest rates, while interest rates
on other types may lag behind changes in market rates. Also, any future
correlation, either in the near term or the long term, between the Company's
common stock equity securities portfolio and the S&P 500 may differ from the
historical correlation as represented by the weighted-average historical beta of
the common stock equity securities portfolio. Accordingly, the market risk
sensitivity analysis may not be indicative of, is not intended to provide, and
does not provide a precise forecast of the effect of changes of market rates on
the Company's income or Shareholders' Equity. Further, the computations do not
contemplate any actions the Company may undertake in response to changes in
interest rates or equity prices.

To the extent that any adverse 100 basis point change occurs in increments over
a period of time instead of instantaneously, the adverse impact on fair values
would be partially mitigated because some of the underlying financial
instruments would have matured. For example, proceeds from any maturing assets
could be reinvested and any new liabilities incurred at the then current
interest rates.

Qualitative Information About Market Risk

Market risk is a broad term related to economic losses due to adverse changes in
the fair value of a financial instrument and is inherent to all financial
instruments. SEC disclosure rules focus on only one element of market
risk--price risk. Price risk relates to changes in the level of prices due to
changes in interest rates, equity prices, foreign exchange rates or other
factors that relate to market volatility of the rate, index, or price underlying
the financial instrument. The Company's primary market risk exposures are to
changes in interest rates and certain exposures to changes in equity prices. The
Company manages its interest rate exposures with respect to Investments in Fixed
Maturities by investing primarily in investment-grade securities of relatively
short duration. The interest rate risks with respect to the fair value of
Consumer Finance Receivables should be partially offset by the impact of
interest rate movements on Investment Certificates and Savings Accounts which
are issued to fund its receivables.

20
At September 30, 2001, $993.8 million of the Company's Investments in Equity
Securities, which exclude the Company's Investments in Investees, was
concentrated in the common and preferred stock of Northrop. Northrop stated in
its 2000 Annual Report on Form 10-K that it is "a leading defense electronics,
systems integration and information technology company" and "Northrop Grumman is
subject to the usual vagaries of the marketplace, it is also affected by the
unique characteristics of the defense industry and by certain elements peculiar
to its own business mix." At September 30, 2001 and December 31, 2000,
respectively, the Company's Investments in Equity Securities included $109.9
million and $160.3 million of Baker Hughes common stock. Baker Hughes stated in
its 2000 Annual Report on Form 10-K that it "is engaged in the oil field and
process industry segments," and that in addition to these industry segments, it
"manufactures and sells other products and provides services to industries not
related to either the petroleum or continuous process industries." Accordingly,
the Company's Investments in Equity Securities are sensitive to the nature of
Northrop and Baker Hughes' industry segments.

Caution Regarding Forward-Looking Statements

Management's Discussion and Analysis of Results of Operations and Financial
Condition, Quantitative and Qualitative Information About Market Risk and the
accompanying Condensed Consolidated Financial Statements (including the notes
thereto) contain forward-looking statements, which usually include words such as
"believe(s)," "goal(s)," "target(s)," "estimate(s)," "anticipate(s),"
"forecast(s)," "plan(s)" and similar expressions. Readers are cautioned not to
place undue reliance on such statements, which speak only as of the date of this
Quarterly Report. Forward-looking statements are subject to risks and
uncertainties which could cause actual results to differ materially from those
contemplated in such statements. Such risks and uncertainties include, but are
not limited to, those described under Items 2 and 3 above, changes in economic
factors (such as interest rates, unemployment rates and stock market
fluctuations), changes in competitive conditions (including availability of
labor with required technical or other skills), the number and severity of
insurance claims (including those associated with catastrophe losses),
regulatory approval of insurance rates, license applications and similar
matters, governmental actions (including new laws or regulations or court
decisions interpreting existing laws and regulations) and adverse judgments in
litigation to which the Company or its subsidiaries are parties. No assurances
can be given that the results contemplated in any forward-looking statements
will be achieved. The Company assumes no obligation to release publicly any
revisions to any forward-looking statements as a result of events or
developments subsequent to the date of this Quarterly Report.

21
PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Information concerning pending legal proceedings is incorporated herein by
reference to Note 9 to the Condensed Consolidated Financial Statements
(Unaudited) in Part I of this Form 10-Q.

Item 6. Exhibits and Reports on Form 8-K

(a) Exhibits.


2.1 Second Amended and Restated Distribution Agreement, dated as of August
17, 2001, between Unitrin, Inc. and Curtiss-Wright Corporation
(incorporated by reference to Exhibit 99.1 to the Company's Amendment
No. 6 to its Schedule 13D with respect to Curtiss-Wright Corporation
dated August 17, 2001.)

2.2 Second Amended and Restated Agreement and Plan of Merger, dated as of
August 17, 2001, among Unitrin, Inc., CW Disposition Company and
Curtiss-Wright Corporation (incorporated by reference to Exhibit 99.2
to the Company's Amendment No. 6 to its Schedule 13D with respect to
Curtiss-Wright Corporation dated August 17, 2001.)

3.1 Certificate of Incorporation (Incorporated herein by reference to
Exhibit 3.1 to the Company's Registration Statement on Form 10 dated
February 15, 1990.)

3.2 Amended and Restated By-Laws (Incorporated herein by reference to
Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for the
quarter ended September 30, 1997.)

4 Rights Agreement between Unitrin, Inc. and First Chicago Trust Company
of New York, as rights agent, dated as of August 3, 1994 (incorporated
herein by reference to Exhibit 1 to the Company's Registration
Statement on Form 8-A dated August 3, 1994), as amended by Letter
Agreement between Unitrin, Inc. and First Union National Bank, dated
October 12, 2000, pursuant to which First Union National Bank was
appointed as successor rights agent under such Rights Agreement,
effective October 30, 2000 (included as Exhibit 4 to Unitrin's Annual
Report on Form 10-K, filed February 1, 2001.)

10.1 Unitrin, Inc. 1990 Stock Option Plan as amended and restated
(Incorporated herein by reference to Exhibit 10.1 to the Company's
Quarterly Report on Form 10-Q for the quarter ended June 30, 1999.)

10.2 Unitrin, Inc. 1997 Stock Option Plan as amended and restated
(Incorporated herein by reference to Exhibit 10.2 to the Company's
Quarterly Report on Form 10-Q for the quarter ended June 30, 1999.)

10.3 Unitrin, Inc. 1995 Non-Employee Director Stock Option Plan as amended
and restated (Incorporated herein by reference to Exhibit 10.3 to the
Company's Quarterly Report on Form 10-Q for the quarter ended June 30,
1999.)

10.4 Unitrin, Inc. Pension Equalization Plan (Incorporated herein by
reference to Exhibit 10.4 to Company's Annual Report on Form 10-K for
the year ended December 31, 1994.)

22
10.5 Unitrin is a party to individual severance agreements (the form of
which is incorporated herein by reference to Exhibit 10.5 to the
Company's 1994 Annual Report on Form 10-K), with the following
executive officers:

Richard C. Vie (Chairman, President and Chief Executive Officer)
David F. Bengston (Vice President)
Eric J. Draut (Senior Vice President, Treasurer & Chief Financial
Officer)
Edward J. Konar Vice President)
Scott Renwick (General Counsel and Secretary)
Richard Roeske (Vice President & Chief Accounting Officer)
Donald G. Southwell (Senior Vice President)

(Note: Each of the foregoing agreements is identical except that the
severance compensation multiple is 2.99 for Mr. Vie and 2.0 for the
other executive officers. The term of these agreements has been
extended by action of Unitrin's board of directors until January 1,
2002.)

10.6 Severance Compensation Plan After Change of Control (Incorporated
herein by reference to Exhibit 10.6 to the Company's 1994 Annual Report
on Form 10-K; the term of this plan has been extended by Unitrin's
board of directors through January 1, 2002.)

10.7 1998 Bonus Plan for Senior Executives (Incorporated herein by reference
to Exhibit A of the Company's Proxy Statement, dated April 9, 1998, in
connection with Company's annual meeting of shareholders.)

10.8 Amended and Restated Credit Agreement, dated September 17, 1997 among
Unitrin, Inc., the Lenders party thereto, and NationsBank of Texas,
N.A. as Administrative Agent (Incorporated herein by reference to
Exhibit 10.7 to the Company's Quarterly Report on Form 10-Q for the
quarter ended September 30, 1997. Pursuant to the terms of such
agreement, the Company's borrowing capacity thereunder was increased to
$440 million, effective March 28, 2000.)

(b) Reports on Form 8-K.

No reports on Form 8-K were filed by the Company during the quarter ended
September 30, 2001.

23
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

Unitrin, Inc.


Date: October 24, 2001 /s/ Richard C. Vie
-------------------------------------------
Richard C. Vie
Chairman, President
and Chief Executive Officer



Date: October 24, 2001 /s/ Richard Roeske
-------------------------------------------
Richard Roeske
Vice President and Chief Accounting Officer
(Principal Accounting Officer)

24